OxVax Ltd.
PrivateLast Round
Seed
Apr 21, 2021
Total Funding Raised
$1M
Company Overview
OxVax Ltd. is a biotechnology company that develops an advanced next-generation dendritic cell vaccine platform for the treatment of solid tumor cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OxVax Ltd. Comparables
Compare OxVax Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Corner Therapeutics | 82% | |
| Diakonos Oncology | 78% | |
| Asgard Therapeutics | 76% | |
OxVax Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 21, 2021 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2021
$1M raised with Evotec as lead investor.
OxVax Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OxVax Ltd.'s valuation, stock price, and market status.